nference and Rush University System for Health Launch Long-Term Partnership to Advance AI-Enabled Clinical Research and Patient Care

Real-world data suggested the dual GLP-1/GIP receptor agonist tirzepatide (Mounjaro, Zepbound) was associated with greater weight loss,

GLP-1s and Muscle Loss; 'Ozempic Personality'

Harness diverse real-world data types to gain insights across genomic, clinical, and operational dimensions

Data Modality

Therapeutic Areas

nference’s platform and tools transform real world data into actionable insights for healthcare innovation.

Join leaders across biopharma, clinical research, data science, and healthcare to explore how AI is advancing immunology research—from decoding complex disease biology to accelerating evidence generation and improving translational decision-making.

Join our upcoming events to explore the latest industry trends, discover technological breakthroughs, and gain expert insights. Network with leaders and stay at the forefront of healthcare innovation.

Streamline research with AI-powered tools that transform complex data into actionable medical insights

nSights

Revolutionize drug development through AI-driven insights, accelerating timelines and improving clinical trial outcomes.

Nucleus

Explore nference products designed to transform healthcare data into actionable insights across research, drug development, and healthcare.

GLP-1 receptor agonists (GLP-1RAs) such as semaglutide and tirzepatide have transformed obesity care and weight management, delivering unprecedented levels of weight loss in real-world practice.

What happens to weight after we stop prescribing GLP-1 therapies?

Characterization of Patients With Narcolepsy Treated vs Not Treated With Sodium Oxybate: A Propensity Score–Matched Cohort Study

Associations of the Fibrosis-4 Index With Rates of Cardiac Events and Liver Decompensation, and the Potential Implications on Risk Stratification in Patients With Nonalcoholic Steatohepatitis.

nference's extensive library of publications showcase cutting-edge research and healthcare advancements.

Blogs

nference Establishes AI Initiative with Takeda to Advance Precision Medicine in Inflammatory Bowel Disease

News

Our latest blogs and insights cover industry trends, technological breakthroughs, and expert insights, to keep you updated on the forefront of healthcare innovation.

Cutting-edge AI solutions to transform cardiac care

Empowering digital pathology with a new WSI paradigm